Uveitis refers to inflammatory and infectious diseases in and around the eye. These conditions are often associated with systemic diseases, including sarcoidosis, lupus, multiple sclerosis, and rheumatoid arthritis. Colorado Retina is a tertiary referral center for patients with these complex diseases, seeing patients from Colorado and seven surrounding states from Montana to New Mexico. In many cases uveitis is treated with immunosuppression therapy to prevent additional flares and damage, and Colorado Retina is proud to offer these treatments, including an intravenous infusion suite in our Parker, Colorado office. We work closely with rheumatology, neurology, infectious disease, and many other subspecialists to create a network of physicians dedicated to the treatment of uveitis and autoimmune eye disease.
Dr. Mark Dacey is very active in the field of uveitis on local, national, and international levels. He has written many peer-reviewed articles in major journals and been invited to speak at national and international uveitis symposiums. He has been a primary investigator on many of the major uveitis studies in the past decade, including several active clinical research trials, to bring cutting-edge technologies to Colorado patients. Dr. Dacey has also served as an advisor and consultant, working closely with companies to develop and bring these exciting new technologies to become available to our patients.
Dr. Ashleigh Levison, in addition to her work in medical and surgical treatment of retinal disease, also cares for patients with uveitis, also known as inflammatory diseases of the eye. Dr. Levison grew up in the world of medicine, as both her parents practiced, she always knew she too wanted to be a doctor. Why uveitis? Levison says, “Because most people identify vision as their most important and valued sense. It is amazing to be able to save and protect the sight of my patients”. Dr. Levison is actively involved in the academia community, she has published several educational papers and often travels to share her advanced research and knowledge of uveitis with her ophthalmic colleagues.